The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced.


The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced construction.

On April 28, a grand groundbreaking ceremony was held for the Phase II project of the Feiman Bio Changchun Jingyue Factory, which is being constructed by the Group. Zhang Jian, General Manager of the company, Xu Bing, Deputy General Manager, and other senior executives attended the ceremony.

This project is being developed under an engineering, procurement, and construction (EPC) contracting model, with a planned gross floor area exceeding 20,000 square meters and a contract value of more than RMB 200 million. Construction is being undertaken by the Group’s Jinhui Branch. Leveraging Feiman Bio’s technological breakthroughs in the field of active collagen, the project will establish a full-industry-chain ecosystem spanning research and development to production, with the aim of setting a benchmark for the biopharmaceutical industry. At the groundbreaking ceremony, General Manager Zhang Jian delivered a speech, stating that Jiangsu Qian’an will fully leverage its expertise in pharmaceutical infrastructure construction, honor its commitments through pragmatic action, and reciprocate the trust placed in it with uncompromising quality. Mr. Zhang urged the project team to spare no effort in creating greater value for the client, ensuring the project’s high-quality execution, and ushering in a new chapter of mutually beneficial cooperation between the two parties. The successful commencement ceremony marks the entry of Jiangsu Qian’an’s collaboration with Feiman Biotechnology into a new phase, while also underscoring Jiangsu Qian’an’s professional expertise and technological strengths in the pharmaceutical infrastructure sector. Moving forward, the two parties will leverage this project as a strategic link to further deepen their cooperation, jointly driving innovation and development in the biopharmaceutical and medical aesthetics industries, and contributing to regional economic growth and industry advancement. (Jinhui Branch)

Recommended news


The Kuaike Haofudun project, undertaken by the Group, has officially entered production, and General Manager Zhang Jian was invited to attend the opening ceremony.

On the morning of June 25, the grand opening ceremony of Quake Haofudun Materials Technology (Suzhou) Co., Ltd. was held in the Zhangjiagang Free Trade Zone. Zhang Jian, General Manager of the Group, along with Deputy General Manager Shi Saicai and other invited guests, attended the event and jointly witnessed this significant milestone marking the project’s entry into production.


The Group achieved excellent results in the preliminary round of the province-wide construction safety production knowledge competition.

Recently, the preliminary-round results of the province-wide construction‑site safety production knowledge competition were officially announced. The Group achieved an outstanding team performance, with six participants ranking in the top ten, placing first among all construction enterprises in the province.


The Group’s Roche Pharmaceutical project employs air‑suspended air cushions to achieve non‑destructive construction.

In mid-June, the Roche Pharmaceuticals project, constructed by the Group’s Maosheng International Engineering Branch, successfully completed the indoor relocation of three 13-ton heavy-duty pieces of equipment within a high‑standard epoxy flooring area, utilizing an air‑suspension cushion‑lifting technique.


Carrying forward the glory of military service, we uphold our spirit of dedication to peace and security.

On June 2, the “Carrying Forward the Glory of Military Service, Ensuring the Well-being of Veteran Soldiers” Care Foundation was officially established at the Qidong Municipal Bureau of Veterans Affairs and the Municipal Charity Federation, under the leadership of Gong Shancong, Deputy General Manager of the Group. The foundation aims to “show care for veterans, alleviate their difficulties, safeguard their health and well-being, and spread warmth throughout society.”


The Group’s Roche Pharmaceutical Project has been awarded the One-Million-Safety-Hours Award.

On June 5, the Roche (Shanghai) Biopharmaceutical Production Base Project (Phase I) held a ceremony to celebrate reaching one million safe man-hours, and the Group was presented with a commemorative trophy.


The Group convened a special meeting of the dedicated task force for major project services.

On the afternoon of May 25, the Group convened a special working meeting on major project services in the 16th-floor conference room, with senior management and all members of the Major Project Management Department in attendance. The meeting was chaired by Zhang Jian, General Manager of the Group.